Skip to main content

Peer Review reports

From: Frequency of pharmacogenomic variants affecting efficacy and safety of anti-cancer drugs in a south Asian population from Sri Lanka

Original Submission
17 Dec 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
9 Jan 2024 Reviewed Reviewer Report - Masahiro Hiratsuka
10 Jan 2024 Reviewed Reviewer Report - Guangzhao Qi
16 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Reviewed Reviewer Report
31 Mar 2024 Author responded Author comments - Priyanga Ranasinghe
Resubmission - Version 3
31 Mar 2024 Submitted Manuscript version 3
11 Apr 2024 Reviewed Reviewer Report - Guangzhao Qi
13 Apr 2024 Reviewed Reviewer Report
16 Apr 2024 Reviewed Reviewer Report
9 May 2024 Author responded Author comments - Priyanga Ranasinghe
Resubmission - Version 4
9 May 2024 Submitted Manuscript version 4
10 May 2024 Author responded Author comments - Priyanga Ranasinghe
Resubmission - Version 5
10 May 2024 Submitted Manuscript version 5
Publishing
20 May 2024 Editorially accepted
24 May 2024 Article published 10.1186/s12920-024-01919-2

You can find further information about peer review here.

Back to article page